ArticleBMC cardiovascular disorders2025

Hemorrhage risk associated with triple antithrombotic therapy: a focused real-world pharmacovigilance disproportional analysis study.

Kannan Sridharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.